Clinical Trial Update: Prevention of Relapse With Injectable Paliperidone Palmitate Versus Oral Antipsychotics [Phase 3]

View source ↗

Summary

Phase 3 trial comparing injectable paliperidone palmitate with oral antipsychotics for relapse prevention in schizophrenia; the study is completed and results w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• INVEGA SUSTENNA (PALIPERIDONE PALMITATE)

Snippet

Sponsor: Janssen-Cilag International NV | Conditions: Schizophrenia | Phase 3 | Status: COMPLETED | Results posted: 2015-02-18